Miami Thyroid Oncology Symposium New Date: April 9 and 10, 2021

Miami Cancer Research Center remains alert and vigilant to the ongoing coronavirus (COVID-19) pandemic. Adapting and responding to uncertainty remains the focus of our plan moving forward. The 4th Annual Miami Thyroid Oncology Symposium will take place on April 9 and April 10, 2021. Registration begins September 1, 2020.

Learn More

Miami Cancer Research Center

Mission

Miami Cancer Research Center (MCRC) is a scientific and charitable organization that performs and supports cancer research, organizes educational events and provides support for cancer care at institutional and individual levels.

A Message from Dr. Seza Gulec, MD, President & CEO

A Message from Dr. Seza Gulec, MD, President & CEO

Welcome to our website. Here you will be able to explore news, research and educational opportunities to deepen understanding of the complex world of cancer. It is my hope that together we will find new ways of meeting the needs of patients, families and the medical community facing this difficult disorder.

Read More

Editorial: Surgical Oncology in times of COVID-19

Editorial: Surgical Oncology in times of COVID-19

While COVID-19 infection continues to spread worldwide at an exponential pace, surgical oncologists and other cancer specialists need to adapt to the new situation to keep providing the same quality and cutting-edge care to our patients

Learn More

Translational Research

MCRCI’s main interest is developing theranostic strategies for solid tumors through translational research. Our translational research tools for theranostics are molecular imaging and genomic profiling. Patient-specific (individualized) treatment protocols are generated for surgical and nuclear medicine treatments.

Learn More

News & Events

The 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo

The 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo

The 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation.

Read More

Defining cancer oncobiology based on genomic and epigenomic expressions

Defining cancer oncobiology based on genomic and epigenomic expressions

We have entered in a personalized medicine paradigm with molecular theranostics. We are defining cancer oncobiology based on genomic and epigenomic expressions

Read More

Innovation

ThyroSeq® presented the results of its prospective, double-blind, multi-center international study today, at the 87th Annual Meeting of the American Thyroid Association (ATA) in Victoria, BC, Canada.

Read More